Long-Term Effect of a Vaccine Targeting Endothelin-1 Receptor Type A in Pulmonary Arterial Hypertension

Background: Previously, we invented a therapeutic vaccine targeting the endothelin-A receptor (termed ETRQβ-002). ETRQβ-002 successfully prevented the remodeling of pulmonary arterioles (PAs) and right ventricle (RV) without significant immune-mediated damage in experimental pulmonary arterial hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Yong, Qiu, Zhihua, Ma, Wenrui, Li, Chang, Chen, Xiao, Song, Xiaoxiao, Bai, Zeyang, Shi, Dingyang, Zheng, Jiayu, Pan, Guangwei, Liao, Yuhua, Liao, Mengyang, Zhou, Zihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247646/
https://www.ncbi.nlm.nih.gov/pubmed/34222378
http://dx.doi.org/10.3389/fcvm.2021.683436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247646/
https://www.ncbi.nlm.nih.gov/pubmed/34222378
http://dx.doi.org/10.3389/fcvm.2021.683436

Ejemplares similares